ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
종양 프로파일링 시장 규모는 향후 몇 년 동안 빠르게 성장할 것으로 예상되며, 2029년에는 10.1%의 연평균 복합 성장률(CAGR)로 164억 8,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안 예상되는 성장은 액체생검 기술 채택 증가, 암 연구 개발 투자 증가, 고령화, 표적치료제 사용 확대, 암 연구 협력 증가 등의 요인에 기인하는 것으로 보입니다. 이 기간을 형성할 것으로 예상되는 주요 동향으로는 동반진단으로의 전환, 다중 유전자 검사 증가, 차세대 시퀀싱 기술 혁신, 암 진단에 인공지능(AI)의 통합, 종양 프로파일링 기술의 발전 등이 있습니다.
맞춤형 의료에 대한 수요 증가는 향후 몇 년 동안 종양 프로파일링 시장의 성장을 가속할 것으로 예측됩니다. 맞춤의료는 환자 개개인의 특성에 맞게 의료 치료를 조정하는 것으로, 기존 치료와 비교하여 더 나은 결과와 부작용이 적고 더 정확한 치료를 제공합니다. 종양 프로파일링은 환자의 종양에서 특정 유전자 변이 및 바이오마커를 식별하여 부작용을 최소화하는 표적 치료를 가능하게 함으로써 맞춤의료에서 중요한 역할을 하고 있습니다. 예를 들어, 2024년 2월, 미국에 기반을 둔 개인맞춤의료 추진 단체인 개인맞춤의료연합(Personalized Medicine Coalition)은 2023년 신약 승인 건수에서 개인맞춤의료가 차지하는 비율이 1/3을 넘어섰으며, 이러한 추세는 4년 연속으로 지속될 것이라고 보고했습니다. 그 결과, 맞춤형 의료에 대한 수요 증가가 종양 프로파일링 시장의 성장을 견인하고 있습니다.
종양 프로파일링 시장의 주요 기업들은 암 치료의 정확성과 효율성을 향상시키기 위해 인공지능(AI) 기반 진단 도구를 포함한 첨단 솔루션 개발에 점점 더 집중하고 있으며, AI는 복잡한 유전체, 프로테옴 및 임상 데이터를 분석하기 위한 고급 컴퓨팅 기술을 포함하고 있습니다. 보다 빠른 진단, 개인화된 치료 계획, 더 나은 병상 진행 모니터링이 용이해집니다. 예를 들어, 2025년 1월 암 진단 및 치료를 위한 AI 기반 소프트웨어 전문 기업인 영국의 Panakeia Technologies LTD는 PANProfiler Colon을 발표했습니다. 이 AI 기반 소프트웨어는 대장암 조직 샘플의 H 및 E 염색 이미지를 사용하여 마이크로 위성 불안정성(MSI) 및 불일치 복구 결손(dMMR)과 같은 주요 분자 바이오마커를 프로파일링하도록 특별히 고안되었습니다. 이 도구는 종양의 신속하고 정확한 분자 프로파일링을 가능하게 하여 대장암 진단, 린치 증후군 식별 및 맞춤 치료 결정에 매우 중요한 역할을 합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계 종양 프로파일링 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 종양 프로파일링 시장 : 성장률 분석
세계의 종양 프로파일링 시장 실적 : 규모와 성장, 2019-2024
세계의 종양 프로파일링 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계 종양 프로파일링 전체 시장(TAM)
제6장 시장 세분화
세계의 종양 프로파일링 시장 : 기술별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
유전체학
단백질체학
에피제네틱스
대사체학
세계의 종양 프로파일링 시장 : 기술별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
시퀀싱 기술
정량적 중합효소 연쇄반응(qPCR)
면역조직화학
In Situ Hybridization (ISH)
마이크로어레이
세계의 종양 프로파일링 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
맞춤형 암 치료
종양 진단
연구
세계의 종양 프로파일링 시장 : 유전체학별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
차세대 시퀀싱(NGS)
중합효소 연쇄반응(PCR)
마이크로어레이
생어-시퀀싱
세계의 종양 프로파일링 시장 : 단백질체학 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
질량분석(MS)
단백질 마이크로어레이
면역조직화학(IHC)
웨스턴 블로팅
세계의 종양 프로파일링 시장 : 에피제네틱스 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 종양 프로파일링 시장 : 대사체학 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
핵자기공명(NMR) 분광법
가스 크로마토그래피 질량분석(GC-MS)
액체 크로마토그래피 질량분석(LC-MS)
모세관 전기영동 질량분석(CE-MS)
제7장 지역별/국가별 분석
세계의 종양 프로파일링 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 종양 프로파일링 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
종양 프로파일링 시장 : 경쟁 구도
종양 프로파일링 시장 : 기업 개요
F. Hoffmann-La Roche AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Thermo Fisher Scientific Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Agilent Technologies Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Hologic Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Illumina Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Sysmex Corporation
QIAGEN N.V.
Exact Sciences Corporation
Guardant Health Inc.
GenScript Biotech Corporation
NeoGenomics Inc.
Caris Life Sciences Inc.
Tempus Inc.
Foundation Medicine Inc.
NanoString Technologies Inc.
Personalis Inc.
Boreal Genomics Inc.
Strand Life Sciences Pvt. Ltd.
HTG Molecular Diagnostics Inc.
Lucence Health Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
종양 프로파일링 시장(2029년) : 새로운 기회를 제공하는 국가
종양 프로파일링 시장(2029년) : 새로운 기회를 제공하는 부문
종양 프로파일링 시장(2029년) : 성장 전략
시장 동향에 근거한 전략
경쟁 전략
제36장 부록
LSH
영문 목차
영문목차
Tumor profiling is a collection of methods used to examine and characterize the genetic and molecular characteristics of a tumor. This process helps identify specific mutations, gene expression patterns, and other molecular traits of cancer cells, providing valuable insights into the biology of the tumor. It also aids in treatment decision-making and supports the development of personalized therapies.
The primary techniques used in tumor profiling include genomics, proteomics, epigenetics, and metabolomics. Genomics involves studying the genetic material (DNA) of cancer cells to identify genetic alterations that drive tumor formation and progression. It uses technologies such as sequencing, quantitative polymerase chain reaction (qPCR), immunohistochemistry, in situ hybridization (ISH), and microarrays. These techniques are commonly applied in personalized cancer treatment, oncological diagnostics, and research.
The tumor profiling market research report is one of a series of new reports from The Business Research Company that provides tumor profiling market statistics, including tumor profiling industry global market size, regional shares, competitors with a tumor profiling market share, detailed tumor profiling market segments, market trends and opportunities, and any further data you may need to thrive in the tumor profiling industry. This tumor profiling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The tumor profiling market size has grown rapidly in recent years. It will grow from $10.16 billion in 2024 to $11.21 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historic period can be attributed to several factors, including the rising prevalence of cancer cases, growing demand for personalized medicine, increased healthcare spending, wider adoption of companion diagnostics, and heightened awareness of the importance of early cancer detection.
The tumor profiling market size is expected to see rapid growth in the next few years. It will grow to $16.48 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth anticipated during the forecast period can be attributed to factors such as the increasing adoption of liquid biopsy techniques, rising investments in cancer research and development, an aging population, the expanding use of targeted therapies, and a growing number of cancer research collaborations. Key trends expected to shape this period include a shift toward companion diagnostics, an increase in multi-gene testing, technological innovations in next-generation sequencing, the integration of artificial intelligence (AI) in cancer diagnostics, and advancements in tumor profiling technologies.
The growing demand for personalized medicine is expected to fuel the growth of the tumor profiling market in the coming years. Personalized medicine tailors healthcare treatments to the unique characteristics of each patient, offering more precise therapies with better outcomes and fewer side effects compared to traditional treatments. Tumor profiling plays a key role in personalized medicine by identifying specific genetic mutations and biomarkers in a patient's tumor, enabling targeted therapies that minimize side effects. For example, in February 2024, the Personalized Medicine Coalition, a U.S.-based organization focused on advancing personalized medicine, reported that personalized medicines accounted for over one-third of all new drug approvals in 2023, marking the fourth consecutive year of this trend. As a result, the rising demand for personalized medicine is driving the expansion of the tumor profiling market.
Leading companies in the tumor profiling market are increasingly focusing on developing advanced solutions, including artificial intelligence (AI)-powered diagnostic tools, to improve the accuracy and efficiency of cancer treatment. AI involves the use of advanced computational techniques to analyze complex genomic, proteomic, and clinical data, facilitating faster diagnoses, personalized treatment plans, and better disease progression monitoring. For example, in January 2025, Panakeia Technologies LTD, a UK-based company specializing in AI-driven software for cancer diagnosis and treatment, introduced PANProfiler Colon. This AI-powered software is specifically designed to profile key molecular biomarkers, such as microsatellite instability (MSI) and mismatch repair deficiency (dMMR), using H and E-stained images of colon cancer tissue samples. The tool allows for rapid and precise molecular profiling of tumors, which is crucial for diagnosing colorectal cancer, identifying Lynch syndrome, and guiding personalized treatment decisions.
In February 2024, Myriad Genetics Inc., a U.S.-based leader in genetic testing and precision medicine, acquired assets from Intermountain Precision Genomics (IPG) for an undisclosed amount. This acquisition bolsters Myriad's precision oncology portfolio by incorporating IPG's precise tumor test, precise liquid test, and its CLIA-certified laboratory in St. George, Utah, all aimed at advancing patient care. Intermountain Precision Genomics is a US-based division specializing in molecular diagnostics, genomic testing, and tumor profiling.
Major players in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., and Predictive Oncology Inc.
North America was the largest region in the tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in tumor profiling report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the tumor profiling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The tumor profiling market includes revenues earned by entities by providing services such as biomarker testing, methylation profiling, and clinical trial matching. The market value includes the value of related goods sold by the service provider or included within the service offering. The tumor profiling market also includes sales of liquid biopsy kits, immunohistochemistry (IHC) kits, and methylation profiling kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified.
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Tumor Profiling Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on tumor profiling market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for tumor profiling ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tumor profiling market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Technique: Genomics; Proteomics; Epigenetics; Metabolomics
2) By Technology: Sequencing Techniques; Quantitative Polymerase Chain Reaction (qPCR); Immunohistochemistry; In Situ Hybridization (ISH); Microarray
3) By Application: Personalized Cancer Medicine; Oncological Diagnostics; Research
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Tumor Profiling Market Characteristics
3. Tumor Profiling Market Trends And Strategies
4. Tumor Profiling Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Tumor Profiling Growth Analysis And Strategic Analysis Framework
5.1. Global Tumor Profiling PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Tumor Profiling Market Growth Rate Analysis
5.4. Global Tumor Profiling Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Tumor Profiling Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Tumor Profiling Total Addressable Market (TAM)
6. Tumor Profiling Market Segmentation
6.1. Global Tumor Profiling Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genomics
Proteomics
Epigenetics
Metabolomics
6.2. Global Tumor Profiling Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sequencing Techniques
Quantitative Polymerase Chain Reaction (qPCR)
Immunohistochemistry
In Situ Hybridization (ISH)
Microarray
6.3. Global Tumor Profiling Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Personalized Cancer Medicine
Oncological Diagnostics
Research
6.4. Global Tumor Profiling Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Next-Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Microarrays
Sanger sequencing
6.5. Global Tumor Profiling Market, Sub-Segmentation Of Proteomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mass Spectrometry (MS)
Protein Microarrays
Immunohistochemistry (IHC)
Western Blotting
6.6. Global Tumor Profiling Market, Sub-Segmentation Of Epigenetics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
